Guy Levy - Net Worth and Insider Trading
Guy Levy Net Worth
The estimated net worth of Guy Levy is at least $5 Million dollars as of 2024-11-10. Guy Levy is the Director of BioAtla Inc and owns about 2,247,524 shares of BioAtla Inc (BCAB) stock worth over $5 Million. Details can be seen in Guy Levy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Guy Levy has not made any transactions after 2021-08-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Guy Levy
Guy Levy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Guy Levy owns 2 companies in total, including Lyra Therapeutics Inc (LYRA) , and BioAtla Inc (BCAB) .
Click here to see the complete history of Guy Levy’s form 4 insider trades.
Insider Ownership Summary of Guy Levy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LYRA | Lyra Therapeutics Inc | 2020-04-30 | 10 percent owner |
| BCAB | BioAtla Inc | 2021-08-24 | director & 10 percent owner |
Guy Levy Latest Holdings Summary
Guy Levy currently owns a total of 1 stock. Guy Levy owns 2,247,524 shares of BioAtla Inc (BCAB) as of August 24, 2021, with a value of $5 Million.
Latest Holdings of Guy Levy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCAB | BioAtla Inc | 2021-08-24 | 2,247,524 | 2.11 | 4,742,276 |
Holding Weightings of Guy Levy
Guy Levy Form 4 Trading Tracker
According to the SEC Form 4 filings, Guy Levy has made a total of 3 transactions in BioAtla Inc (BCAB) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in BioAtla Inc is the sale of 546,709 shares on August 24, 2021, which brought Guy Levy around $22 Million.
Insider Trading History of Guy Levy
- 1
Guy Levy Trading Performance
GuruFocus tracks the stock performance after each of Guy Levy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Guy Levy is 102.6%. GuruFocus also compares Guy Levy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Guy Levy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Guy Levy's insider trading performs compared to the benchmark.
Performance of Guy Levy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 29.66 | | | | | |
| Relative Return to S&P 500(%) | 28.07 | | | | | |
Guy Levy Ownership Network
Ownership Network List of Guy Levy
Ownership Network Relation of Guy Levy
Guy Levy Owned Company Details
What does Lyra Therapeutics Inc do?
Who are the key executives at Lyra Therapeutics Inc?
Guy Levy is the 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Lyra Therapeutics Inc (LYRA) Insider Trades Summary
Over the past 18 months, Guy Levy made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.
Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lyra Therapeutics Inc Insider Transactions
Guy Levy Mailing Address
Above is the net worth, insider trading, and ownership report for Guy Levy. You might contact Guy Levy via mailing address: C/o Soleus Private Equity Gp I, Llc, 104 Field Point Road, 2nd Floor, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
